A new study of the first 400 patients to be prescribed CBD oil in New Zealand suggests that the cannabinoid may be beneficial for treating patients suffering with symptoms of non-cancer pain and mental health conditions.
CBD is more popular than ever in the UK, but its testing standards are hardly high, say the ACI.
Recreational cannabis stores have been closed in Massachusetts since March 24 after being ruled to be “non-essential” businesses.
From 2018 to 2019, global legal cannabis sales grew by 46 percent up to US$14.8 billion, according to new analysis.
The new report, which analysed transactions on the darknet, found that illicit cannabis sales increased by about 30 percent during the first quarter of 2020.
The analytical services of CannaSafe, one of California’s larger cannabis testing lab companies, will soon be available in three more US states.
Supplied by the Latin American company Khiron Life Sciences, the cannabis products will first be issued to UK doctors before being prescribed to the 20,000 patients expected to be involved in the trial.
Although no such breathalyzer has yet been made, the researchers claim their test is inexpensive and effective enough to hold promise for future practical devices.
The $9 million donation will help fund research at Harvard Medical School into how full-spectrum cannabis products differ to those made from a single extracted compound.